European Medicines Agency

• The EU Ozempic probe is expanding. What you should know

  The agency began its review after Iceland's health regulator flagged reports of patients thinking about suicide and one case of thoughts of self harm after use of Novo's drugs.

  Health

  Jul 11
  
• Ozempic, Saxenda drugs under EU probe over reports of suicidal thoughts

  The review has been announced weeks after the regulator raised a thyroid cancer safety signal on several of Novo's products that contain semaglutide.

  Health

  Jul 10
  
• Advertisement
• Why rare blood clots could be a side effect of AstraZeneca COVID-19 vaccine

  Medical experts are learning more about the possible link between the AstraZeneca COVID-19 vaccine and potentially dangerous blood clots, as well as why they might happen.

  Canada

  Apr 7, 2021
• Advertisement
• Morning-after pill OK for heavier women: European regulator

  A commonly used morning-after pill is suitable for use by heavier women, a European regulator said Thursday, following claims that the drug didn't work for women over 176 lbs.

  Health

  Jul 24, 2014